Advertisement

Document › Details
Bruker Corporation. (1/4/22). "Press Release: Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference". Billerica, MA.
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 40th annual J.P. Morgan Healthcare Conference, to be held virtually on January 10-13, 2022. Frank Laukien, Chairman, President & CEO and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 10th, 2022 at 9:00 AM Eastern Standard Time.
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.
Investor Contact:
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com
Record changed: 2023-06-05 |
Advertisement

More documents for Bruker (Group)
- [1] Bruker Corporation. (10/4/23). "Press Release: Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)". Zürich....
- [2] Bruker Corporation. (10/3/23). "Press Release: Bruker Completes Acquisition of PhenomeX". Billerica, MA....
- [3] Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan....
- [4] Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA....
- [5] Bruker Corporation. (6/2/23). "Press Release: Bruker Corporation to Present at Jefferies 2023 Healthcare Conference". Billerica, MA....
- [6] Bruker Corporation. (5/8/23). "Press Release: Bruker Announces Acquisition of Zontal to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions". Billerica, MA....
- [7] Berkeley Lights, Inc.. (3/21/23). "Press Release: Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company". Emeryville, CA....
- [8] Bruker Corporation. (1/5/23). "Press Release: Bruker Announces Acquisition of Acquifer Imaging GmbH". Heidelberg....
- [9] Bruker Corporation. (1/4/23). "Press Release: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers". Lausanne....
- [10] Bruker Corporation. (12/21/22). "Press Release: Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference". Billerica, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top